FDA Issues Warning Letter to Rolence Ent.
November 09, 2024
November 09, 2024
WASHINGTON, Nov. 9 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Rolence Ent. Inc.:
* * *
To: Chang Lin Chiu, General Manager, Rolence Ent. Inc., No. 18-3, Lane 231 Pu Chung Road, Taoyuan District, Taoyuan City 32083, Taiwan, (b)(4)@rolence.com.tw
Dear Chang Lin Chiu:
During an inspection of your firm located in Taoyuan, Taiwan on July 8, 2024, through July 11, 2024, an i . . .
* * *
To: Chang Lin Chiu, General Manager, Rolence Ent. Inc., No. 18-3, Lane 231 Pu Chung Road, Taoyuan District, Taoyuan City 32083, Taiwan, (b)(4)@rolence.com.tw
Dear Chang Lin Chiu:
During an inspection of your firm located in Taoyuan, Taiwan on July 8, 2024, through July 11, 2024, an i . . .